These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 28532811)
21. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. Davies DH; McCausland MM; Valdez C; Huynh D; Hernandez JE; Mu Y; Hirst S; Villarreal L; Felgner PL; Crotty S J Virol; 2005 Sep; 79(18):11724-33. PubMed ID: 16140750 [TBL] [Abstract][Full Text] [Related]
22. Short-term and longer-term protective immune responses generated by subunit vaccination with smallpox A33, B5, L1 or A27 proteins adjuvanted with aluminum hydroxide and CpG in mice challenged with vaccinia virus. Xiao Y; Zeng Y; Schante C; Joshi SB; Buchman GW; Volkin DB; Middaugh CR; Isaacs SN Vaccine; 2020 Aug; 38(38):6007-6018. PubMed ID: 32741672 [TBL] [Abstract][Full Text] [Related]
23. Immunologic evaluation of 10 different adjuvants for use in vaccines for chickens against highly pathogenic avian influenza virus. Lone NA; Spackman E; Kapczynski D Vaccine; 2017 Jun; 35(26):3401-3408. PubMed ID: 28511853 [TBL] [Abstract][Full Text] [Related]
24. The bovine viral diarrhea virus E2 protein formulated with a novel adjuvant induces strong, balanced immune responses and provides protection from viral challenge in cattle. Snider M; Garg R; Brownlie R; van den Hurk JV; van Drunen Littel-van den Hurk S Vaccine; 2014 Nov; 32(50):6758-64. PubMed ID: 25454860 [TBL] [Abstract][Full Text] [Related]
25. Humoral and T cell-mediated immune responses to bivalent killed bovine viral diarrhea virus vaccine in beef cattle. Platt R; Coutu C; Meinert T; Roth JA Vet Immunol Immunopathol; 2008 Mar; 122(1-2):8-15. PubMed ID: 18190971 [TBL] [Abstract][Full Text] [Related]
26. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions. Fogg C; Lustig S; Whitbeck JC; Eisenberg RJ; Cohen GH; Moss B J Virol; 2004 Oct; 78(19):10230-7. PubMed ID: 15367588 [TBL] [Abstract][Full Text] [Related]
28. Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia Virus. Medaglia ML; Moussatché N; Nitsche A; Dabrowski PW; Li Y; Damon IK; Lucas CG; Arruda LB; Damaso CR J Virol; 2015 Dec; 89(23):11909-25. PubMed ID: 26378174 [TBL] [Abstract][Full Text] [Related]
29. No significant differences in the breadth of the foot-and-mouth disease serotype A vaccine induced antibody responses in cattle, using different adjuvants, mixed antigens and different routes of administration. Tekleghiorghis T; Weerdmeester K; van Hemert-Kluitenberg F; Moormann RJ; Dekker A Vaccine; 2014 Sep; 32(41):5330-6. PubMed ID: 25092634 [TBL] [Abstract][Full Text] [Related]
30. Educational Approach to Prevent the Burden of Vaccinia Virus Infections in a Bovine Vaccinia Endemic Area in Brazil. Barbosa Costa G; Silva de Oliveira J; Townsend MB; Carson WC; Borges IA; McCollum AM; Kroon EG; Satheshkumar PS; Reynolds MG; Nakazawa YJ; de Souza Trindade G Pathogens; 2021 Apr; 10(5):. PubMed ID: 33922509 [TBL] [Abstract][Full Text] [Related]
31. Adsorption of recombinant poxvirus L1-protein to aluminum hydroxide/CpG vaccine adjuvants enhances immune responses and protection of mice from vaccinia virus challenge. Xiao Y; Zeng Y; Alexander E; Mehta S; Joshi SB; Buchman GW; Volkin DB; Middaugh CR; Isaacs SN Vaccine; 2013 Jan; 31(2):319-26. PubMed ID: 23153450 [TBL] [Abstract][Full Text] [Related]
32. Effect of the Route of Administration of the Vaccinia Virus Strain LIVP to Mice on Its Virulence and Immunogenicity. Shchelkunov SN; Yakubitskiy SN; Sergeev AA; Kabanov AS; Bauer TV; Bulychev LE; Pyankov SA Viruses; 2020 Jul; 12(8):. PubMed ID: 32722032 [TBL] [Abstract][Full Text] [Related]
33. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge. Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639 [TBL] [Abstract][Full Text] [Related]
34. Early protection against foot-and-mouth disease virus in cattle using an inactivated vaccine formulated with Montanide ESSAI IMS D 12802 VG PR adjuvant. Quattrocchi V; Pappalardo JS; Langellotti C; Smitsaart E; Fondevila N; Zamorano P Vaccine; 2014 Apr; 32(19):2167-72. PubMed ID: 24631088 [TBL] [Abstract][Full Text] [Related]
35. Antibody titers to vaccination are not predictive of level of protection against a BVDV type 1b challenge in Bos indicus - Bos taurus steers. Downey-Slinker ED; Ridpath JF; Sawyer JE; Skow LC; Herring AD Vaccine; 2016 Sep; 34(42):5053-5059. PubMed ID: 27601344 [TBL] [Abstract][Full Text] [Related]
36. Seroprevalence of bovine vaccinia in cows and its correlation with the productive profile of affected farms in Distrito Federal, Brazil. Silva LF; de Oliveira SAM; de Alencar Mota ALA; Gonçalves VSP; de Oliveira Freitas C; Cargnelutti JF; Flores EF; de Sant'Ana FJF Braz J Microbiol; 2022 Mar; 53(1):411-419. PubMed ID: 34729709 [TBL] [Abstract][Full Text] [Related]
37. Vaccinia virus Transmission through Experimentally Contaminated Milk Using a Murine Model. Rehfeld IS; Guedes MI; Fraiha AL; Costa AG; Matos AC; Fiúza AT; Lobato ZI PLoS One; 2015; 10(5):e0127350. PubMed ID: 26000966 [TBL] [Abstract][Full Text] [Related]
38. A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost. Xiao Y; Aldaz-Carroll L; Ortiz AM; Whitbeck JC; Alexander E; Lou H; Davis HL; Braciale TJ; Eisenberg RJ; Cohen GH; Isaacs SN Vaccine; 2007 Jan; 25(7):1214-24. PubMed ID: 17098336 [TBL] [Abstract][Full Text] [Related]
39. Long-lasting stability of Vaccinia virus strains in murine feces: implications for virus circulation and environmental maintenance. Abrahão JS; Trindade Gde S; Ferreira JM; Campos RK; Bonjardim CA; Ferreira PC; Kroon EG Arch Virol; 2009; 154(9):1551-3. PubMed ID: 19710997 [TBL] [Abstract][Full Text] [Related]
40. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]